💊 NSAID · GI & Renal Injury

Ibuprofen: Nursing Drug Guide, GI Bleeding, Renal Injury & NCLEX Review

One of the most common inpatient and OTC analgesics—and one of the easiest to duplicate. Before every dose, reconcile hidden NSAIDs, screen for aspirin-sensitive asthma, and watch for GI bleeding and rising creatinine when ibuprofen stacks with anticoagulants, ACE inhibitors, or diuretics.

⏱️15 min read
📅Updated May 28, 2026
Pharmacist Reviewed
🚨 Major safety note — NSAID cardiovascular and GI risk

NSAIDs including ibuprofen increase the risk of serious cardiovascular thrombotic events (myocardial infarction and stroke) and serious GI adverse events (bleeding, ulceration, perforation), which can be fatal. Ibuprofen is contraindicated for peri-operative pain in CABG surgery and in patients with aspirin-sensitive asthma or prior serious NSAID reactions. Because ibuprofen is widely available OTC, nurses must catch duplicate NSAID exposure—scheduled hospital ibuprofen plus home naproxen, ketorolac, or topical NSAIDs is a common source of preventable GI bleeding and acute kidney injury. Highest-risk patients include older adults on warfarin or other anticoagulants, those with heart failure, renal impairment, and prior peptic ulcer or GI bleeding. Use the lowest effective dose for the shortest duration and escalate immediately for melena, hematemesis, oliguria, chest pain, or stroke symptoms.

Quick facts

💊
Class
NSAID (nonselective)
➡️
Route
Oral (Rx & OTC)
📐
Usual adult dose
400 mg q4–6h PRN
⚠️
Main risk
GI bleed & AKI risk

💡 Key takeaway

Before every ibuprofen dose, confirm no duplicate NSAID exposure (including OTC Advil/Motrin at home), verify aspirin-sensitive asthma and NSAID allergy history, and assess for GI bleeding, oliguria, and cardiovascular red flags—especially when ibuprofen is combined with anticoagulants, ACE inhibitors, or diuretics in older adults.

💊

Most common brand names

Ibuprofen appears as prescription tablets (400 mg, 600 mg, 800 mg) and widely as OTC products including Advil, Motrin, and store brands (typically 200 mg). Suspensions and chewables exist for pediatric OTC use per product labeling. Patients often say “Motrin” while the MAR lists generic ibuprofen—always reconcile strength and total daily dose across routes and products.

Do not confuse ibuprofen with acetaminophen (different toxicity profile—no NSAID GI/renal boxed warnings) or with other NSAIDs (naproxen, ketorolac, meloxicam, celecoxib) when reconciling therapy. Duplicate NSAID exposure dramatically increases GI bleeding and renal risk per NSAID class labeling.

🎯

Why we give it — Indications

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase, reducing prostaglandin-mediated pain, fever, and inflammation. Prescription ibuprofen tablets are indicated for rheumatoid arthritis, osteoarthritis, mild to moderate pain, and primary dysmenorrhea per labeling. OTC products are labeled for fever and minor aches and pains per individual product monographs. Nurses must match the order to the correct strength and ensure total daily dose from all ibuprofen sources stays within prescriber and labeling limits.

Use Detail
Rheumatoid arthritis Relief of signs and symptoms of rheumatoid arthritis per ibuprofen tablet labeling (1200–3200 mg/day divided).
Osteoarthritis Relief of signs and symptoms of osteoarthritis.
Mild to moderate pain 400 mg every 4 to 6 hours as necessary; doses above 400 mg were not more effective than 400 mg in controlled analgesic trials per labeling.
Primary dysmenorrhea 400 mg every 4 hours as necessary beginning at earliest onset of menstrual pain per labeling.

On a small screen, swipe or scroll sideways to see the full table.

🔬

How it works

Ibuprofen inhibits cyclooxygenase enzymes, decreasing prostaglandin synthesis involved in pain, fever, and inflammation. Like other NSAIDs, it carries a boxed warning for serious cardiovascular thrombotic events and serious GI bleeding. Ibuprofen is rapidly absorbed with peak serum levels generally in one to two hours; the serum half-life is approximately 1.8 to 2.0 hours. NSAIDs may reduce renal perfusion in patients who depend on prostaglandins—especially when combined with furosemide, thiazides, or ACE inhibitors such as enalapril.

📐

Dosing overview

Use the lowest effective dose for the shortest duration consistent with treatment goals. Verify indication, hepatic and renal function, concurrent anticoagulant or diuretic therapy, and all other NSAID sources before administration. Do not exceed 3200 mg total daily dose for prescription ibuprofen tablets per labeling.

Mild–moderate pain
400 mg q4–6h
PRN; >400 mg not more effective in trials
RA / OA (chronic)
1200–3200 mg/day
Divided TID/QID; tailor to response
Dysmenorrhea
400 mg q4h
Start at earliest pain onset
OTC products
200 mg typical
Follow product label max daily dose
Renal impairment
Avoid advanced disease
Not recommended in advanced renal disease; monitor closely if used
Pediatrics (Rx tablets)
Not established
Safety/effectiveness of Rx tablets in children not established per labeling; OTC pediatric dosing per product label

Administration tip: If GI complaints occur, administer with meals or milk per labeling.

Missed dose: If a scheduled dose is missed, give when remembered unless the next dose is due soon—do not double doses. For PRN regimens, do not exceed daily maximum per prescriber order and labeling.

⏱️

Onset, peak, duration, and half-life

ParameterValueNursing relevance
OnsetAnalgesic effect may begin within hours; peak serum levels generally 1–2 hours after oral doseReassess pain using structured pain assessment after a reasonable interval
Peak1–2 hours after administration (prescription tablet labeling)PRN timing should respect minimum interval (typically q4–6h)
Half-lifeApproximately 1.8–2.0 hours for unchanged ibuprofenShort half-life; risk is cumulative daily dose and drug interactions, not single long half-life
DurationSupports q4–6h PRN and divided chronic regimensDo not add another NSAID while ibuprofen is on the MAR or home list

On a small screen, swipe or scroll sideways to see the full table.

🛡️

Before you give it — Safety check

Pretreatment checks

  • Perform medication reconciliation—screen for duplicate NSAIDs, aspirin, anticoagulants, ACE inhibitors, ARBs, and diuretics
  • Review allergy history: ibuprofen, aspirin/NSAID reactions, aspirin-sensitive asthma, prior serious NSAID skin reactions
  • Assess cardiovascular history, blood pressure, edema, renal function (BUN/creatinine), and prior GI bleeding or peptic ulcer disease
  • Confirm surgical plan—hold per protocol before CABG; NSAIDs are contraindicated for CABG pain

Contraindications

  • Known hypersensitivity to ibuprofen or any formulation excipient
  • History of asthma, urticaria, or allergic-type reactions after aspirin or other NSAIDs
  • Use in the setting of coronary artery bypass graft (CABG) surgery
  • Prior serious skin reactions to NSAIDs (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis) per labeling warnings

Important interactions

Drug / class Effect Nursing action
Warfarin / anticoagulants Increased bleeding risk; NSAIDs may affect anticoagulant control Monitor INR and bleeding; report melena, hematuria, or bruising when combined with warfarin
Other NSAIDs / aspirin Additive GI bleeding and cardiovascular risk; aspirin may reduce ibuprofen efficacy Do not administer duplicate NSAID therapy without prescriber intent; clarify low-dose aspirin plans
ACE inhibitors / ARBs / diuretics NSAIDs may reduce antihypertensive effect and worsen renal function in susceptible patients Monitor blood pressure, weight, edema, and renal trends on basic metabolic panel
Lithium / methotrexate / digoxin NSAIDs may increase serum levels or toxicity of these agents per NSAID class labeling Flag to pharmacy; monitor levels and toxicity symptoms per institutional protocol
Other NSAIDs / ketorolac / naproxen Additive GI bleeding, renal injury, and cardiovascular risk—common when hospital ibuprofen overlaps home OTC NSAIDs Hold duplicate NSAID doses; clarify postoperative and PRN analgesia plans; teach patients not to double OTC products

On a small screen, swipe or scroll sideways to see the full table.

➡️

Administration

Oral tablets: Available as 200 mg (OTC), 400 mg, 600 mg, and 800 mg prescription strengths. Swallow with water; may take with food or milk if GI upset occurs per labeling.

OTC counseling: Many patients self-treat with Advil or Motrin at home—always ask about OTC ibuprofen during admission and teach not to exceed labeled daily maximums or combine with prescription NSAIDs unless directed.

  • Confirm home OTC NSAIDs, low-dose aspirin, and herbal antiplatelet supplements are documented after reconciliation
  • Document indication, dose, route, time, and pain score before and after PRN doses
  • Ensure fall-risk precautions in older adults with orthostatic symptoms, especially when bleeding or anemia develops
⚠️ Duplicate NSAID and daily maximum discipline

Cardiovascular and GI risks increase with higher cumulative daily doses and longer duration. Count all ibuprofen sources—scheduled doses, PRN doses, and home OTC products—before administering. Reconcile whether ibuprofen is still needed at each care transition.

📈

Expected therapeutic response

  • Improved pain score or joint stiffness with functional mobility gains in arthritis
  • Reduced swelling and tenderness on joint exam when inflammation is present
  • No new GI bleeding, blood pressure elevation, edema, or renal function decline while therapy continues
🚨

Red flags — Stop and act

Hold ibuprofen and escalate immediately when serious NSAID complications are suspected.

  • Black stool, hematemesis, coffee-ground emesis, or severe abdominal pain suggesting GI bleeding
  • Chest pain, sudden weakness, facial droop, slurred speech, or other stroke or MI symptoms
  • New or worsening dyspnea, rapid weight gain, or peripheral edema in patients with heart failure
  • Decreased urine output, rising creatinine, or hyperkalemia suggesting acute kidney injury
  • Urticaria, facial swelling, wheezing, or anaphylaxis after a dose
  • Jaundice, dark urine, or persistent nausea with rising AST/ALT on liver function tests
⚠️

Adverse effects

Adverse effectFrequency / severityNursing response
Dyspepsia, abdominal pain, diarrheaCommon in arthritis trialsAssess for bleeding vs irritation; hold and notify if severe or accompanied by melena
Peripheral edema, hypertensionCommon; may worsen heart failureMonitor weight, blood pressure, and lung sounds; notify if decompensation suspected
Serious GI bleeding / perforationSerious; boxed warningHold NSAID, obtain hemoglobin, notify prescriber, prepare for urgent GI evaluation
MI / strokeSerious; boxed warningHold dose, obtain vital signs and ECG per protocol, activate emergency pathway for acute symptoms
Renal impairmentSerious in susceptible patientsMonitor intake/output and BMP; hold if acute kidney injury develops
HepatotoxicitySerious; uncommonMonitor LFTs when ordered; discontinue if persistent abnormalities or clinical hepatitis
Serious skin reactions / anaphylaxisRare but potentially fatalStop permanently; treat hypersensitivity per protocol; document allergy

On a small screen, swipe or scroll sideways to see the full table.

☠️

Overdose, toxicity, and antidote

Symptoms following acute NSAID overdosage are typically limited to lethargy, drowsiness, nausea, vomiting, and epigastric pain, which are generally reversible with supportive care. Gastrointestinal bleeding has occurred. Hypertension, acute renal failure, respiratory depression, and coma have occurred but were rare per ibuprofen tablet labeling. Case reports include apneic/cyanotic infants after large ingestions and dizziness after very high adult doses.

Management

  • No specific antidote—provide symptomatic and supportive care
  • Empty the stomach by vomiting or lavage if ingestion was recent (little drug recovered if >1 hour elapsed per labeling)
  • Consider oral activated charcoal; alkali and diuresis may be theoretically beneficial because ibuprofen is acidic and renally excreted
  • Monitor airway, breathing, renal function, and GI bleeding; pediatric ingestions warrant close observation even if initially stable
📞Poison control

Contact local poison control or medical toxicology services for overdose guidance per facility protocol and local emergency guidance.

🔤

Look-alike / sound-alike and error prevention

  • Ibuprofen vs acetaminophen (Tylenol)—patients and staff confuse OTC analgesics; verify active ingredient before PRN pain doses
  • Ibuprofen vs indomethacin / ketorolac—all are NSAIDs but differ in potency and renal/GI risk; read back generic name and strength on verbal orders
  • Strength errors—confirm 200 mg OTC vs 400/600/800 mg prescription tablets; pediatric liquid mg/mL differs from tablet milligrams
  • Duplicate NSAID therapy—scheduled ibuprofen plus PRN naproxen, ketorolac, or home Advil is a common inpatient error
  • Combination products—cold/flu remedies may contain hidden ibuprofen or other NSAIDs; review full ingredient list on reconciliation
🛏️

Practical bedside notes

TopicBedside guidance
Food timingMay take with or without food; offer food or milk if GI upset occurs per labeling.
OTC overlapAsk specifically about Advil, Motrin, and menstrual pain products—patients may not report them as “medications.”
Anticoagulant patientsPrioritize bleeding assessments and INR trends at each visit when warfarin is co-ordered.
Diuretic / ACE inhibitor patientsTrack weight, blood pressure, intake/output, and creatinine—NSAID-induced AKI can develop within days.
PerioperativeContraindicated for peri-operative CABG pain; hold per surgical NSAID protocols for other procedures.
Ask pharmacy whenUnclear total daily NSAID load, interaction with lithium or methotrexate, or whether to switch to non-NSAID analgesia in high-risk patients.

On a small screen, swipe or scroll sideways to see the full table.

👥

High-risk populations

Population Considerations
Older adults Higher risk of GI bleeding, renal dysfunction, and cardiovascular events—use lowest dose, monitor closely, and avoid long duration without clear benefit.
Prior peptic ulcer / GI bleeding Significantly increased risk of serious GI events; coordinate gastroprotection and prescriber risk-benefit discussion before restarting NSAIDs.
Heart failure / cardiovascular disease Avoid in severe heart failure unless benefit outweighs risk; monitor blood pressure, edema, and symptoms of decompensation.
Renal impairment / dehydration NSAIDs may worsen renal perfusion—avoid in advanced renal disease; monitor creatinine and electrolytes when ACE inhibitors or diuretics are co-prescribed.
Pregnancy Avoid at about 30 weeks gestation and later (ductus arteriosus closure). Between about 20 and 30 weeks, use lowest effective dose for shortest duration; consider ultrasound monitoring if use extends beyond 48 hours per labeling.
Lactation LactMed reports low milk levels and minimal infant exposure at usual doses; still coordinate with prescriber—benefits of breastfeeding vs potential infant effects.

On a small screen, swipe or scroll sideways to see the full table.

📊

Monitoring and documentation

Monitor

  • Pain and function using structured pain assessment and mobility goals
  • GI status—stool color, hemoglobin trend, and symptoms of bleeding or ulcer
  • Blood pressure, weight, edema, and heart failure symptoms
  • Renal function and electrolytes on BMP when diuretics, ACE inhibitors, or ARBs are co-administered
  • INR and bleeding signs when anticoagulants are used
  • LFTs when hepatic risk factors or symptoms are present

Document

  • Dose, route, time, indication, and pain score response for PRN doses
  • Allergy verification (NSAID, aspirin-sensitive asthma, prior serious skin reaction)
  • Patient education on bleeding, cardiovascular symptoms, and when to seek urgent care
  • Hold parameters communicated to patient and on the MAR per institutional policy
💬

Patient teaching

  • Take exactly as prescribed—do not combine with other ibuprofen, naproxen, ketorolac, or aspirin products unless your prescriber directs you to; count OTC Advil/Motrin toward your daily total
  • Report black or bloody stools, vomiting blood, severe stomach pain, chest pain, shortness of breath, sudden weakness, facial swelling, or rash immediately
  • NSAIDs can raise blood pressure and cause swelling—report rapid weight gain or ankle swelling
  • Tell all clinicians you take ibuprofen before surgery, dental procedures, or new prescriptions
  • If you use topical gel, wash hands after application and keep the medicated area away from infants’ skin and eyes
  • Pregnancy planning: discuss risks with your prescriber—avoid late-pregnancy use per labeling

The Hold Rule

Do not give and contact the prescriber/pharmacist when:

The Hold Rule — When to pause and clarify
  • Known ibuprofen or NSAID hypersensitivity; aspirin-sensitive asthma history
  • Suspected GI bleeding, melena, hematemesis, or severe abdominal pain
  • Chest pain, stroke symptoms, or peri-CABG period when NSAIDs are contraindicated
  • Acute kidney injury, oliguria, or rapidly rising creatinine while on NSAID plus diuretic/ACE inhibitor
  • Supratherapeutic INR or active bleeding on anticoagulation without prescriber clearance
  • Duplicate NSAID order would result from administering the scheduled dose (including hidden OTC ibuprofen/naproxen)
  • Late pregnancy (avoid NSAIDs that may cause ductus arteriosus closure) unless prescriber documents exceptional benefit

Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.

🩺

Clinical practice integration and workflow

Ibuprofen feels routine because it is OTC—but inpatient NSAID boxed warnings still apply. Build duplicate-NSAID checks, GI bleeding screens, and renal trend review into every administration pass, especially for older adults on anticoagulants, ACE inhibitors, and diuretics.

1. Check-before-you-give protocol

  • Right patient, drug, dose, route, time—and no duplicate NSAID on the MAR, OTC list, or topical products
  • Allergy screen includes NSAID reactions and aspirin-sensitive asthma
  • Bleeding assessment and stool color when anticoagulated or prior PUD
  • Blood pressure and weight trend when heart failure or diuretics are present

2. High-alert and safety badge

NSAID boxed warning — cardiovascular and GI risk

Treat ibuprofen with NSAID safety discipline: lowest dose, shortest duration, no duplicate NSAIDs, and immediate hold for bleeding or chest pain.

3. Clinical workflow: hold and question rules

  • If the patient reports black stools while on ibuprofen and warfarin, hold the dose and notify the prescriber before the next administration
  • If orthopedic or surgical teams order ibuprofen postoperatively, confirm the patient is not also receiving another NSAID PRN on the MAR
  • Reconcile chronic home OTC ibuprofen at discharge—ensure patients know total daily maximum and when to avoid NSAIDs

4. Critical teach-back questions

  • “Which over-the-counter pain medicines should you avoid while taking prescription ibuprofen?” (Patient should name Advil/Motrin/naproxen/other NSAIDs and know acetaminophen is a different drug unless prescriber directs otherwise.)
  • “What bleeding or heart symptoms mean you should seek care immediately?” (Black stool, vomiting blood, chest pain, sudden weakness, trouble breathing.)

5. Care coordination

Pharmacist: Review anticoagulant interactions, CYP2C9 status, hepatic dosing, duplicate NSAID therapy, and gastroprotection needs

Prescriber: Notify for GI bleeding, chest pain, rising creatinine, hypertensive crisis, or need for alternative analgesia in high-risk patients

🧠 Quick mental checklist

  • Is the patient taking any other NSAID, aspirin, or OTC Advil/Motrin besides this order?
  • Any aspirin-sensitive asthma, NSAID allergy, or prior serious NSAID skin reaction?
  • Any black stool, anemia, or abdominal pain while on ibuprofen?
  • On warfarin or anticoagulant—when was INR last checked?
  • Creatinine, blood pressure, and intake/output trend acceptable before I give this dose?
📚

Ibuprofen NCLEX practice questions

Practice NCLEX-style clinical judgment practice for ibuprofen using a tabbed inpatient case (MAR, labs, I&O, nursing notes), then priority action, cue recognition, trend interpretation, ordered escalation steps, documentation cloze, and matrix urgency sorting—recognise duplicate NSAID risk → analyse renal/GI trends → prioritise holds → act → evaluate outcomes.

Select a tab to view MAR, labs, I&O, and nursing note details for this case.

Medication administration record — today
  • Ibuprofen 600 mg PO q6h PRN pain — last given 0600; next due 1200
  • Lisinopril 20 mg PO daily — given 0800
  • Furosemide 40 mg PO daily — given 0800
  • Warfarin 5 mg PO daily — given 1800 yesterday; INR due today
  • Acetaminophen 650 mg PO q6h PRN — not given in last 24 h
  • No scheduled NSAID besides ibuprofen PRN on MAR
Question 1 — Priority action

After reviewing the MAR, labs, I&O, and nursing notes, what is the nurse’s best FIRST action at 1400?

Question 2 — Recognize cues

Which findings in this case increase concern for serious NSAID-related complications? Select all that apply

Question 3 — Trend interpretation

Compared with admission, today’s data show:

Trend snapshot
INR 2.0 → 2.9; Hgb 13.2 → 11.4 g/dL in 24 h
Creatinine 1.1 → 1.6 mg/dL; BUN 24 → 32 mg/dL; urine output 450 mL/24 h
BP 132/78 → 102/64 with dizziness; weight +1.8 kg; melena reported; home naproxen reconciled
Ibuprofen and warfarin held; stool guaiac pending

Select all that apply — which nursing actions are appropriate now?

Question 4 — Ordered response

Rank the nurse’s actions from first (1) to last (5) when melena and oliguria occur in a patient on ibuprofen, warfarin, and furosemide.

  1. Hold scheduled/PRN ibuprofen and warfarin doses
  2. Notify prescriber and pharmacist of GI bleeding concern and elevated INR
  3. Obtain vital signs and assess orthostatic changes
  4. Collect stool guaiac or send specimen per protocol
  5. Document patient report, holds, and notifications in the record
Question 5 — Documentation cloze

Before administering ibuprofen, the nurse verifies the patient has no history of and no per ibuprofen contraindications.

Question 6 — Matrix judgment

For each finding, select the best nursing urgency category (one per row).

Finding Expected Concerning Requires immediate follow-up
OA pain 4/10; stable vitals; urine output adequate; no GI symptoms; INR 2.1 on prior check
New ankle edema, 1.8 kg weight gain, and oliguria on ibuprofen plus furosemide
Melena, Hgb drop, INR 2.9 on warfarin plus ibuprofen and home naproxen; BP 102/64 with dizziness
Mild dyspepsia relieved by food; stool brown; hemoglobin stable

On a small screen, swipe or scroll sideways to see the full table.

Answer key & rationale

Frequently asked questions

What GI and renal risks must nurses monitor with ibuprofen?

Ibuprofen carries an NSAID boxed warning for serious cardiovascular thrombotic events and serious GI bleeding, ulceration, and perforation, which can be fatal. NSAIDs may cause renal papillary necrosis and renal injury, especially in patients with renal impairment, dehydration, heart failure, or those taking ACE inhibitors or diuretics. Elderly patients and those with prior peptic ulcer disease or GI bleeding are at higher GI risk. Because ibuprofen is OTC, duplicate NSAID exposure is a common preventable trigger.

When should a nurse hold ibuprofen and contact the prescriber or pharmacist?

Hold for suspected GI bleeding (melena, hematemesis, severe abdominal pain), chest pain or stroke symptoms, acute kidney injury or oliguria, hepatotoxicity signs, ibuprofen or NSAID hypersensitivity, aspirin-sensitive asthma history, planned or recent CABG, or INR or bleeding concerns when combined with warfarin. Also hold if duplicate NSAID therapy would occur from hospital ibuprofen plus home naproxen, ketorolac, or other NSAIDs.

Can ibuprofen be used with warfarin?

Ibuprofen labeling states that although short-term studies did not show large INR changes, bleeding has been reported when NSAIDs and coumarin-type anticoagulants are used together, and the effects on GI bleeding are synergistic. Monitor INR and bleeding signs closely, especially in older adults with renal impairment or prior GI bleeding. Report melena, bruising, or supratherapeutic INR promptly.

What is the maximum daily dose of prescription ibuprofen?

Prescription ibuprofen tablets should not exceed 3200 mg total daily dose per labeling. For mild to moderate pain, 400 mg every 4 to 6 hours as needed is recommended, and doses greater than 400 mg were not more effective in controlled analgesic trials. Always include OTC ibuprofen sources when calculating total daily exposure.

Is ibuprofen safe during pregnancy or breastfeeding?

Avoid ibuprofen in late pregnancy because NSAIDs may cause premature closure of the ductus arteriosus per labeling. Use during pregnancy only if potential benefit justifies potential risk; adequate well-controlled studies in pregnant women are not available (Pregnancy Category C). LactMed reports extremely low milk levels and considers ibuprofen a preferred analgesic in nursing mothers at usual doses.

What is the treatment for ibuprofen overdose?

There is no specific antidote. Manage with symptomatic and supportive care per NSAID overdosage guidance. Gastric emptying and activated charcoal may be considered for recent ingestions. Monitor airway, breathing, GI bleeding, and renal function—especially in pediatric overdoses. Contact local poison control or medical toxicology services per facility protocol.

📚

References

  1. U.S. National Library of Medicine. Ibuprofen tablets, USP — Full prescribing information. DailyMed.
    https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07506e83-e681-4225-8c65-3e8d21d69064
  2. U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA strengthens warning that NSAIDs increase heart attack and stroke risk.
    https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-prescription-nsaids-increase-heart-attack-stroke-risk
  3. Drugs and Lactation Database (LactMed). Ibuprofen. Bethesda (MD): National Institute of Child Health and Human Development; updated August 15, 2025.
    https://www.ncbi.nlm.nih.gov/books/NBK500986/
🔐

Review and transparency

This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.

Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.